Revisiting the initial diagnosis and blood staging of mycosis fungoides and Sézary syndrome with the KIR3DL2 marker.
Fiche publication
Date publication
juin 2020
Journal
The British journal of dermatology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BENSUSSAN Armand
Tous les auteurs :
Roelens M, de Masson A, Ram-Wolff C, Maki G, Cayuela JM, Marie-Cardine A, Bensussan A, Toubert A, Bagot M, Moins-Teisserenc H
Lien Pubmed
Résumé
The early diagnosis of Sézary syndrome (SS) is challenging. Loss of CD7 and CD26 expression on CD4 T cells is the currently used criterion in the initial diagnosis and staging of patients with SS.
Mots clés
Humans, Mycosis Fungoides, diagnosis, Prospective Studies, Receptors, KIR3DL2, Reproducibility of Results, Sezary Syndrome, diagnosis, Skin Neoplasms, diagnosis
Référence
Br J Dermatol. 2020 06;182(6):1415-1422